Latest

1 story

Hide weekly roundups

Thursday, July 23

NuCana's NuTide:303 trial for NUC-3373 combos terminated; results posted with 19 enrolled

Trial updatefosifloxuridine nafalbenamide NuCana plc

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.